Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administration
- PMID: 1432613
- DOI: 10.1002/jps.2600811013
Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administration
Abstract
A pharmacokinetic model with multiple, unequal, enterohepatic recirculations was developed to fit the experimental data of a new inotropic drug after intravenous infusion and oral administration. Optimized model parameters were used to derive theoretical values of the area under the curves of concentration versus time that were in good agreement with the experimental values.
Similar articles
-
Drug recirculation model with multiple cycles occurring at unequal time intervals.J Biomed Eng. 1992 Nov;14(6):521-6. doi: 10.1016/0141-5425(92)90107-v. J Biomed Eng. 1992. PMID: 1434577
-
Estimation of the effective amount entering the body for drugs subject to enterohepatic recirculations.Med Eng Phys. 1995 Apr;17(3):172-6. doi: 10.1016/1350-4533(95)95706-g. Med Eng Phys. 1995. PMID: 7795853
-
Linear pharmacokinetics of a new inotropic agent.Arzneimittelforschung. 1994 Apr;44(4):471-3. Arzneimittelforschung. 1994. PMID: 8010998
-
Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.Clin Pharmacokinet. 2002;41(10):751-90. doi: 10.2165/00003088-200241100-00005. Clin Pharmacokinet. 2002. PMID: 12162761 Review.
-
Efficiency of enterohepatic circulation, its determination and influence on drug bioavailability.Arzneimittelforschung. 1999 Oct;49(10):805-15. doi: 10.1055/s-0031-1300506. Arzneimittelforschung. 1999. PMID: 10554656 Review.
Cited by
-
Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans.AAPS J. 2015 Sep;17(5):1210-23. doi: 10.1208/s12248-015-9764-2. Epub 2015 May 20. AAPS J. 2015. PMID: 25990964 Free PMC article. Clinical Trial.
-
A Continuous Intestinal Absorption Model to Predict Drug Enterohepatic Recirculation in Healthy Humans: Nalbuphine as a Model Substrate.Mol Pharm. 2024 Sep 2;21(9):4510-4523. doi: 10.1021/acs.molpharmaceut.4c00424. Epub 2024 Jul 2. Mol Pharm. 2024. PMID: 38956965 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources